These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2267489)

  • 1. Molecular mechanisms of action of ribavirin.
    Patterson JL; Fernandez-Larsson R
    Rev Infect Dis; 1990; 12(6):1139-46. PubMed ID: 2267489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral activity and mode of action of ribavirin 5'-sulfamate against Semliki Forest virus.
    Smee DF; Alaghamandan HA; Kini GD; Robins RK
    Antiviral Res; 1988 Dec; 10(6):253-62. PubMed ID: 2854956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride.
    Gabrielsen B; Phelan MJ; Barthel-Rosa L; See C; Huggins JW; Kefauver DF; Monath TP; Ussery MA; Chmurny GN; Schubert EM
    J Med Chem; 1992 Aug; 35(17):3231-8. PubMed ID: 1507208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.
    Huggins JW
    Rev Infect Dis; 1989; 11 Suppl 4():S750-61. PubMed ID: 2546248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.
    Vanderlinden E; Vrancken B; Van Houdt J; Rajwanshi VK; Gillemot S; Andrei G; Lemey P; Naesens L
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6679-6691. PubMed ID: 27572398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ribavirin: a clinical overview.
    Fernandez H; Banks G; Smith R
    Eur J Epidemiol; 1986 Mar; 2(1):1-14. PubMed ID: 3021519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antiviral acticity of some phosphates of the broad-spectrum antiviral nucleoside, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin).
    Allen LB; Boswell KH; Khwaja TA; Meyer RB; Sidwell RW; Witkowski JT; Christensen LF; Robins RK
    J Med Chem; 1978 Aug; 21(8):742-6. PubMed ID: 211234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase.
    Cameron CE; Castro C
    Curr Opin Infect Dis; 2001 Dec; 14(6):757-64. PubMed ID: 11964896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.
    Kirsi JJ; North JA; McKernan PA; Murray BK; Canonico PG; Huggins JW; Srivastava PC; Robins RK
    Antimicrob Agents Chemother; 1983 Sep; 24(3):353-61. PubMed ID: 6615611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo Phlebovirus inhibition by ribavirin.
    Sidwell RW; Huffman JH; Barnett BB; Pifat DY
    Antimicrob Agents Chemother; 1988 Mar; 32(3):331-6. PubMed ID: 3129991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
    Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
    J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen.
    Crotty S; Maag D; Arnold JJ; Zhong W; Lau JY; Hong Z; Andino R; Cameron CE
    Nat Med; 2000 Dec; 6(12):1375-9. PubMed ID: 11100123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiviral activity and mechanism of action of (S)-[3-hydroxy-2-(phosphonomethoxy)propyl] (HPMP) nucleosides.
    Magee WC; Evans DH
    Antiviral Res; 2012 Nov; 96(2):169-80. PubMed ID: 22960154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ribavirin in the combination therapy of hepatitis C virus infection.
    Picardi A; Gentilucci UV; Zardi EM; D'Avola D; Amoroso A; Afeltra A
    Curr Pharm Des; 2004; 10(17):2081-92. PubMed ID: 15279547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.
    Kirsi JJ; McKernan PA; Burns NJ; North JA; Murray BK; Robins RK
    Antimicrob Agents Chemother; 1984 Oct; 26(4):466-75. PubMed ID: 6517540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribavirin--current status of a broad spectrum antiviral agent.
    Snell NJ
    Expert Opin Pharmacother; 2001 Aug; 2(8):1317-24. PubMed ID: 11585000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on types 1 and 3 parainfulenza virus infections.
    Sidwell RW; Khare GP; Allen LB; Huffman JG; Witkowski JT; Simon LN; Robins RK
    Chemotherapy; 1975; 21(3-4):205-20. PubMed ID: 169109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of action of ribavirin in antiviral therapies.
    Tam RC; Lau JY; Hong Z
    Antivir Chem Chemother; 2001 Sep; 12(5):261-72. PubMed ID: 11900345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of high RNA virus mutation rates: lethal mutagenesis and the antiviral drug ribavirin.
    Crotty S; Andino R
    Microbes Infect; 2002 Nov; 4(13):1301-7. PubMed ID: 12443894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivirally active ribavirin analogues--4,5-disubstituted 1,2,3-triazole nucleosides: biological evaluation against certain respiratory viruses and computational modelling.
    Krajczyk A; Kulinska K; Kulinski T; Hurst BL; Day CW; Smee DF; Ostrowski T; Januszczyk P; Zeidler J
    Antivir Chem Chemother; 2014 Jan; 23(4):161-71. PubMed ID: 23538746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.